Financials
- Market Capitalization 198.93 M
- Employee 7
- Founded 2007
- CEO N/A
- Website www.minervaneurosciences.com
- Headquarter Massachusetts, United States
- FIGI BBG0067S9Z73
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3629 | NKTX Nkarta, Inc. - Common Stock | 2.79 USD | -6.06% | -15.20% | -6.69% | +47.62% | 199.61 M USD | ||
| 3630 | IMUX Immunic, Inc. - Common Stock | 14.64 USD | -0.88% | -1.61% | +4.87% | +1622.35% | 199.42 M USD | ||
| 3639 | VYGR Voyager Therapeutics, Inc. - Common Stock | 3.24 USD | -5.81% | -11.48% | -8.73% | -30.32% | 195.76 M USD | ||
| 3643 | KRRO Korro Bio, Inc. - Common Stock | 13.50 USD | -7.28% | -3.98% | +14.12% | -65.30% | 194.70 M USD |
Frequently asked questions about Minerva Neurosciences, Inc - Common Stock
What is the Minerva Neurosciences, Inc - Common Stock stock price today?
The current price of Minerva Neurosciences, Inc - Common Stock (NERV) is 4.27. Over the past 24 hours, the stock has changed by -9.53%. Follow the NERV chart for real-time price dynamics.
What is the stock ticker of Minerva Neurosciences, Inc - Common Stock?
Minerva Neurosciences, Inc - Common Stock trades under the ticker NERV. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Minerva Neurosciences, Inc - Common Stock stock going up?
NERV has changed by -13.21% over the last week, -7.38% over the last month, and +142.61% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Minerva Neurosciences, Inc - Common Stock net income for the last quarter?
Minerva Neurosciences, Inc - Common Stock reported net income of -125.4 M for the last quarter. The previous quarter showed -283.67 M, which means net income changed by +55.79%.
How many employees does Minerva Neurosciences, Inc - Common Stock have?
As of the latest available data, Minerva Neurosciences, Inc - Common Stock has 7 employees. Workforce size can provide additional context about the company's scale and operations.
What is Minerva Neurosciences, Inc - Common Stock EBITDA?
Minerva Neurosciences, Inc - Common Stock EBITDA is -16.81 M, and its EBITDA margin is 931.82 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Minerva Neurosciences, Inc - Common Stock stock?
You can buy Minerva Neurosciences, Inc - Common Stock (NERV) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Minerva Neurosciences, Inc - Common Stock stock?
Investing in Minerva Neurosciences, Inc - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NERV chart and related analysis on metatrader.com as part of your research.